Sufentanil

Generic Name
Sufentanil
Brand Names
Dsuvia, Sufenta, Dzuveo
Drug Type
Small Molecule
Chemical Formula
C22H30N2O2S
CAS Number
56030-54-7
Unique Ingredient Identifier
AFE2YW0IIZ
Background

Sufentanil is an opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. It is administered by the intravenous, epidural and sublingual routes.
...

Indication

The indications for this drug are as follows:

Associated Conditions
Acute Pain, Severe Acute Pain
Associated Therapies
General Anesthesia, Induction and Maintenance of General Anesthesia, Lumbar epidural anesthesia therapy, Short opioid analgesia requirement

Low-dose S-ketamine and Dexmedetomidine in Combination With Opioids for Postoperative Analgesia

First Posted Date
2021-03-10
Last Posted Date
2022-12-13
Lead Sponsor
Peking University First Hospital
Target Recruit Count
200
Registration Number
NCT04791059
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2021-01-20
Last Posted Date
2023-07-19
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
3
Registration Number
NCT04716413
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2020-09-23
Last Posted Date
2023-12-13
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
61
Registration Number
NCT04561375
Locations
🇺🇸

Cleveland Clinic Fairview Hospital, Cleveland, Ohio, United States

Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population

First Posted Date
2020-07-09
Last Posted Date
2022-12-12
Lead Sponsor
West Virginia University
Registration Number
NCT04464512
Locations
🇺🇸

West Viriginia University Hospital, Morgantown, West Virginia, United States

Comparison of Meperidine and Sufentanil Added to 0.5% Hyperbaric Bupivacaine for Spinal Anesthesia in Cesarean Section

First Posted Date
2020-06-25
Last Posted Date
2021-07-30
Lead Sponsor
Makassed General Hospital
Target Recruit Count
60
Registration Number
NCT04446715
Locations
🇱🇧

Makassed General Hospital, Beirut, Lebanon

Different Anesthesia Maintain Protocol Effect the Outcome of the Patients

First Posted Date
2020-06-23
Last Posted Date
2020-10-14
Lead Sponsor
China International Neuroscience Institution
Target Recruit Count
50
Registration Number
NCT04443946
Locations
🇨🇳

Xuanwu hospital, Beijing, Beijing, China

Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone

First Posted Date
2020-05-20
Last Posted Date
2024-05-30
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
80
Registration Number
NCT04396587
Locations
🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

Interest of Audiovisual Distraction in the Management of Anxiety and Pain During Oocyte Retrieval

First Posted Date
2019-12-30
Last Posted Date
2021-01-19
Lead Sponsor
CMC Ambroise Paré
Target Recruit Count
36
Registration Number
NCT04213781
Locations
🇫🇷

Hopital FOCH, Suresnes, Ile-de-France, France

Sufentanil Intranasal

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2019-10-23
Last Posted Date
2021-02-05
Lead Sponsor
Centre Hospitalier Universitaire Saint Pierre
Target Recruit Count
170
Registration Number
NCT04137198
Locations
🇧🇪

CHU Saint Pierre, Bruxelles, Belgium

Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2019-10-09
Last Posted Date
2019-10-09
Lead Sponsor
Shengjing Hospital
Target Recruit Count
50
Registration Number
NCT04121416
Locations
🇨🇳

shengjing hospital of China medical university, Shenyang, Liao Ning, China

© Copyright 2024. All Rights Reserved by MedPath